Latest From InnaVirVax SA
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a monthly review of emerging In Vitro Diagnostic, Medical Device, and Pharmaceutical companies that have received venture funding. This month’s column covers deals announced July through August 2015.
START-UP 's monthly comprehensive review of emerging life science companies that have received venture funding during the month, including companies within the in vitro diagnostics, pharmaceuticals, research/analytical equipment & supplies, and medical device sectors.
- In Vitro Diagnostics
- Therapeutic Areas
- Infectious & Viral Diseases
- Western Europe
- Parent & Subsidiaries
- InnaVirVax SA
- Senior Management
Joel Crouzet, CEO
Nathalie Baran, Dir. Finance & Ops.
Raphael H Tsong Fang, Assoc. CMO
- Contact Info
Phone: 1 80 85 60 83
4 rue Pierre Fontaine
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.